- Topical tranexamic acid lightens melasma by interrupting plasmin-driven signals that stimulate pigment cells.
- Trials used 3% and 5% twice daily for 12 weeks and found results similar to hydroquinone, with less irritation.
- Give it about 12 weeks, wear broad-spectrum SPF 30+ with iron oxide every day, and expect melasma to need upkeep.
- Oral TXA works better but is a prescription drug with clot-related contraindications, so it's a decision for your doctor.
Topical tranexamic acid (TXA) is a brightening ingredient that can lighten hyperpigmentation, especially melasma, by calming the signals that tell pigment cells to make more melanin. In clinical trials, 3% and 5% TXA applied twice a day for 12 weeks reduced melasma about as much as hydroquinone, with less irritation. It works slowly and only alongside daily sunscreen.
Below: how TXA works, what the studies actually tested, how to fit a serum into your routine, how it compares with niacinamide and alpha arbutin, and why the pill form is a separate conversation for your doctor. If you want a general plan for fading any kind of spot, our guide on how to fade dark spots covers that; this article stays on TXA.
What is tranexamic acid, and how does it work on pigment?
Tranexamic acid is a drug that was first used to reduce bleeding, and on skin it seems to interrupt a chain of inflammatory signals that push melanocytes to make pigment. TXA is a plasmin inhibitor: it blocks plasminogen from being converted to plasmin. A 2017 review in Dermatologic Therapy explains why that matters for skin: plasminogen also exists in the basal layer of the epidermis, and skin cells called keratinocytes produce plasminogen activator, so there is a biological reason to expect TXA to change how keratinocytes and pigment cells talk to each other.
Researchers describe a few likely effects. A comprehensive melasma review notes that TXA decreases the generation of arachidonic acid, which in turn lowers melanocyte-stimulating hormone and pigment production, and that it may also reduce growth factors linked to blood vessels. DermNet adds that TXA may reduce tyrosinase activity and shrink dermal blood vessels, while stating plainly that the mechanism is not fully understood.
That vascular angle is part of why TXA gets so much attention for melasma, a condition where sunlight, visible light and hormones all play a role. For a closer look at those drivers, see melasma causes and triggers.
Does topical tranexamic acid work for hyperpigmentation?
Yes, for melasma there is reasonable early evidence, though the trials are small and topical TXA is weaker than the oral form. Here is what the main studies found:
- 3% TXA vs hydroquinone plus a steroid: In a 12-week split-face trial of 50 women, a 3% TXA solution on one side and 3% hydroquinone with 0.01% dexamethasone on the other, both twice daily, lowered melasma scores on both sides with no significant difference between them.
- 5% TXA vs 2% hydroquinone: In a randomized, double-blind trial of 60 women, 5% TXA twice daily for 12 weeks lowered the Melasma Area and Severity Index (MASI) about as much as 2% hydroquinone. No side effects were reported in the TXA group, against 10% in the hydroquinone group, and satisfaction was higher with TXA (33.3% vs 6.7%).
- Pooled data: A 2017 meta-analysis of 11 studies with 667 participants found TXA lowered MASI scores alone and as an add-on to standard treatment. Side effects were minor, including transient skin irritation.
The caveats are real. The melasma review above found that topical TXA has had limited success and less efficacy than the oral form, with occasional negative results as a stand-alone treatment and better results in combination with other pigment treatments. The Dermatologic Therapy review concluded that across oral, topical and injected routes, its efficacy is not yet established adequately. DermNet still describes topical 5% TXA as under investigation, with promising results in epidermal-type melasma.
For post-acne marks and sun spots, the evidence is thinner. Most published TXA research is on melasma, so treat any claim that a TXA serum fades every type of dark spot with some skepticism.
What concentration of tranexamic acid should you look for?
Look for a product that states its percentage, and compare it with the 2% to 5% range used in research. The trials above tested 3% and 5%, and the melasma review cites results from topical 2% preparations. Higher is not automatically better: no study we found showed that going above 5% gives faster results.
Many TXA serums pair it with niacinamide, and that combination makes sense because the two act at different steps. A blend can also make it hard to tell which ingredient is doing the work, which matters if you react to it.
How do you use a tranexamic acid serum?
Apply it once or twice a day to clean, dry skin, then follow with moisturizer, and in the morning, sunscreen. The trials used twice-daily application, which is a sensible target once your skin is comfortable with it.
- Start once a day. Spread a few drops over the whole patch of pigmentation, covering the lighter edges as well as the darkest center.
- Layer it early. Thin serums go on after cleansing and before heavier creams.
- Move to twice a day after a week or two if your skin shows no stinging or redness.
- Finish every morning with sunscreen (more on that below).
- Take a photo in the same light every few weeks so you can judge change honestly.
TXA is generally described as gentle, but the meta-analysis did record transient skin irritation in a few cases. If a product burns or stings, stop and try again later at a lower frequency, or switch formulas.
How long does tranexamic acid take to work?
Plan on about 12 weeks before judging a TXA serum, and longer for stubborn melasma. Both topical trials measured their results at 12 weeks. The American Academy of Dermatology says that for melasma treatment in general, it usually takes between 3 and 12 months to see results, and longer if the melasma has been there a long time.
| Time on TXA | What to expect |
|---|---|
| Weeks 1 to 4 | Usually no visible change. Focus on tolerance and consistent sunscreen. |
| Weeks 4 to 8 | Some people notice edges softening; many don't yet. |
| Week 12 | The point at which trials measured their results. Compare photos taken in the same light. |
| 3 to 12 months | The AAD's typical range for melasma treatment results. |
Melasma also returns easily. DermNet and the AAD both stress long-term sun protection, and gains can fade if a summer of unprotected sun undoes them.
Why is sunscreen non-negotiable with tranexamic acid?
Because light keeps restarting pigment production, and no brightening serum can outpace daily exposure. For melasma, the AAD recommends a broad-spectrum sunscreen with SPF 30 or higher, with zinc oxide, titanium dioxide or iron oxide, and notes that a tinted formula can help if a white cast is a concern. Iron oxide matters here because visible light also drives melasma; the melasma review reports that sunscreens with visible-light blockers such as iron oxide reduced melasma relapses compared with UV filters alone.
Most people also apply too little. Our guide on how much sunscreen to use covers amounts and reapplication.
Tranexamic acid vs niacinamide vs alpha arbutin: which should you choose?
Pick TXA first if your main concern is melasma, niacinamide if you want a gentle all-rounder that also helps oil and barrier, and alpha arbutin if your spots are post-acne marks or sun spots and you want a classic tyrosinase inhibitor. They work at different points, so they can be combined.
| Ingredient | Main action | Where the evidence is | Best fit |
|---|---|---|---|
| Tranexamic acid | Blocks plasmin-driven signals that stimulate melanocytes; may affect blood vessels | Small melasma trials at 2% to 5% | Melasma, hormone- and sun-triggered patches |
| Niacinamide | Reduces transfer of pigment from melanocytes to skin cells | Small pigmentation studies, plus wide use for oil and barrier | Mixed concerns: tone, oil, barrier |
| Alpha arbutin | Inhibits tyrosinase, the enzyme that makes melanin | Lab studies and small clinical studies, often in blends | Post-acne marks and sun spots |
For details on the other two, see our guides to niacinamide and alpha arbutin.
What about oral tranexamic acid for melasma?
Oral TXA is a prescription treatment, and only a doctor should decide whether it's right for you. The AAD says that in studies, tranexamic acid decreased melasma patches when other treatments failed, that it's usually prescribed as a twice-daily pill for difficult cases, and that you should tell your dermatologist if you've ever had a blood clot. A 2018 review in Dermatologic Surgery found oral TXA effective for melasma in Asian skin over 8 to 12 weeks and recommends careful screening for contraindications first.
DermNet lists contraindications for tranexamic acid that include a personal or family history of blood clotting problems or venous thromboembolism, ischemic heart disease, stroke and severe kidney problems, and notes that its long-term safety in melasma remains largely unknown. If you're pregnant or breastfeeding, ask your doctor before starting any brightening treatment, topical or oral.
How can a selfie scan help you track a TXA serum?
Melasma fades slowly and unevenly, so it's easy to give up at week six because the mirror shows nothing new. Photos taken in the same light every few weeks are a better test. An app like Pori gives each selfie an overall skin score plus a Pigmentation & Tone reading, so you can compare scans across the 12 weeks instead of relying on memory. With Pori Pro, the ingredient scanner can also read a serum's label and flag each ingredient it knows as beneficial, use with caution or avoid for your skin type.
An app is not a diagnosis. A scan tracks appearance; it can't diagnose melasma or tell it apart from other kinds of pigmentation. A dermatologist should check any patch that is new, spreading or not responding.
When should you see a dermatologist?
See a dermatologist if you're not sure your patches are melasma, if three months of sunscreen and a topical brightener haven't helped, or if you're considering oral TXA. Hydroquinone, the long-standing standard, is no longer available without a prescription in the US, so a visit opens up options you can't buy yourself. Any dark spot that changes shape, color or size needs a professional look before you reach for a serum.
Frequently asked questions
Does tranexamic acid really work for hyperpigmentation?
For melasma, small trials show topical TXA at 3% to 5% lowers severity scores about as much as hydroquinone over 12 weeks. Evidence for post-acne marks and sun spots is thinner.
How long does tranexamic acid take to work?
Studies measured results at 12 weeks of twice-daily use. The AAD says melasma treatment usually takes 3 to 12 months to show results.
Can I use tranexamic acid with niacinamide?
Yes. They act on different steps of pigment production and are often combined in one serum. Introduce one product at a time so you know what caused any irritation.
Is tranexamic acid better than alpha arbutin?
Neither is better for everyone. TXA has more melasma-specific research, while alpha arbutin is a classic tyrosinase inhibitor often chosen for post-acne marks and sun spots.
Is topical tranexamic acid safe?
It's generally well tolerated; a meta-analysis reported only minor side effects such as transient skin irritation. Stop if it burns or stings, and ask a doctor first if you're pregnant or breastfeeding.
Should I take tranexamic acid pills for melasma?
Only if a doctor prescribes them. Oral TXA is used for difficult melasma, but people with a history of blood clots and some other conditions shouldn't take it.
Sources
- American Academy of Dermatology: Melasma: diagnosis and treatment
- DermNet: Tranexamic acid
- Ebrahimi B, Naeini FF. Topical tranexamic acid as a promising treatment for melasma. J Res Med Sci, 2014 (PMC)
- Atefi N et al. Therapeutic effects of topical tranexamic acid in comparison with hydroquinone in treatment of women with melasma. Dermatol Ther (Heidelb), 2017 (PMC)
- Kim HJ et al. Efficacy and safety of tranexamic acid in melasma: a meta-analysis and systematic review. Acta Derm Venereol, 2017 (PubMed)
- Taraz M et al. Tranexamic acid in treatment of melasma: a comprehensive review of clinical studies. Dermatol Ther, 2017 (PubMed)
- Ogbechie-Godec OA, Elbuluk N. Melasma: an up-to-date comprehensive review. Dermatol Ther (Heidelb), 2017 (PMC)
- Bala HR et al. Oral tranexamic acid for the treatment of melasma: a review. Dermatol Surg, 2018 (PubMed)
Pori is a wellness and skincare education app, not a medical device. This article is for general information and isn't medical advice. For anything that worries you, see a dermatologist.



